Implantable Device | sciencenewsnet.in

Breaking News

Transplanting healthy reef ecosystems to damaged reefs improves coral health

Technological Breakthrough in Carbon Nanotube Applications for Battery Dry Process

Lack of control at work identified as cause for physician burnout and attrition

Expanding HPV vaccination to all adults aged 27-45 years unlikely to be cost-effective or efficient for HPV-related cancer prevention

University Student’s Start-Up Expands, Connecting Small Coffee Farmers to the World

FSU physicists will study nuclear reactions of stars with support from National Science Foundation

Warning: don’t miss Thanksgiving dinner, it’s more meaningful than you think

Roswell Park Launches First-of-Its-Kind Oncology Training Program for Nurse-Scientists With $2M NCI Grant

UT Southwestern brings first-of-its-kind radiation oncology to new $177M campus in Fort Worth Medical District

Tips and recipes for a healthy holiday season from a doctor and a dietitian

26 Nov, 2024

Binghamton University researcher to aid innovative Mayo Clinic project to treat inflammatory diseases

November 5, 2024 sarah JonasAnnouncement

Binghamton University, State University of New York will play a key role in a federal grant of up to $42.8 million to develop an implantable device that acts as a living pharmacy to treat inflammatory diseases. Mayo Clinic is the prime site for this groundbreaking research, and researchers at Binghamton will assist with bioengineering the transplanted cells.

Brian Fargo, inXile founder, gives $1 million to advance UCI research for tinnitus treatment

May 19, 2021 sarah JonasAnnouncement

Irvine, Calif., May 19, 2021 — A $1 million gift to the University of California, Irvine from Brian Fargo, founder and studio head of inXile entertainment, will advance efforts to develop a treatment for tinnitus, commonly described as “ringing in the ears.” According to the American Tinnitus Association, an estimated 50 million people in the U.